Teicoplanin

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

NeutropeniaOsteomyelitisAmputationNosocomial InfectionCholangitis

124 competitors in Neutropenia

#DrugCompanyPhaseTrials

1

Teicoplanin

Sanofi

Approved

12

Cubicin

BBaxter Healthcare Corporation

Phase 3

33

Mycostatin

GGood Molecules, LLC

Phase 3

14

Caspofungin Acetate

Merck & Co.

Phase 3

45

Liposomal Lurtotecan

Gilead

Phase 3

16

Amphotericin B Deoxycholate

Merck & Co.

Phase 3

17

Alcohol

Astellas

Phase 3

—8

Cytosar

Teva

Phase 2

19

Medrol

Pfizer

Phase 2

110

G-CSF

AArog Pharmaceuticals, Inc.

Phase 3

3Show 27 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Soft Tissue Infections1 trial

Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections

Terminated·Novartis·Phase 3·NCT00430937·194 enrolled

Nosocomial Infection1 trial

Comparison of Efficacy and Safety of Ceftazidime Avibactam Versus Extended Infusions of High Dose Meropenem in Patients of ACLF With Nosocomial Infections.

Not yet recruiting·IInstitute of Liver and Biliary Sciences, India·N/A·NCT06818565·150 enrolled

Chemotherapy1 trial

Teicoplanin in Treating Septicemia in Patients Who Are Receiving Chemotherapy Through a Central Venous Catheter

Unknown status·CChildren's Cancer and Leukaemia Group·N/A·NCT00024453·1,360 enrolled

Surgical Site Infection1 trial

Does Teicoplanin Powder Use In Lumbar Instrumentation Surgery Reduce Surgical Site Infection

Unknown status·—·Phase 3·NCT04341831·120 enrolled

Cholangitis1 trial

Antibiotics Treatment of Cholangitis Post-Kasai Portoenterostomy

Completed·TTongji Hospital·Phase 4·NCT04370145·160 enrolled

10 more indications

Efficacy and Safety1 trial

Efficacy and Safety of Teicoplanin in CDAD

Terminated·Sanofi·Phase 4·NCT04003818·50 enrolled

Amputation1 trial

The Amputation Surgical Site Infection Trial (ASSIT)

Completed·HHull University Teaching Hospitals NHS Trust·Phase 4·NCT02018094·160 enrolled

Neutropenia1 trial

Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation

Completed·PPETHEMA Foundation··NCT00462878·392 enrolled

Osteomyelitis1 trial

Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci

Completed·Merck & Co.·Phase 2·NCT00428844·75 enrolled

Antibiotics1 trial

Study of Antibiotics in Cerebrospinal Fluid Following Intravenous Injection

Withdrawn·—·Phase 1·NCT00925093

CAR1 trial

TDM-optimized Teicoplanin Dosing Versus Standard of Care

Active, not recruiting·RRadboud University Medical Center·Phase 4·NCT05914467·74 enrolled

Antibiotic1 trial

Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients

Completed·Sanofi·Phase 4·NCT00454272·197 enrolled

Knee Arthroplasty1 trial

Teicoplanin Prophylaxis for Total Hip or Knee Arthroplasty

Completed·UUniversity of Athens·Phase 4·NCT00719056·616 enrolled

Osteoarticular Infections1 trial

Administration of Subcutaneous Teicoplanin in the Treatment of Osteoarticular Infections: Tolerance Study

Completed·—·Phase 2·NCT01815541·30 enrolled

Concentration1 trial

A Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely

Unknown status·NNational Taiwan University Hospital·Phase 4·NCT00368498·20 enrolled

Details

Drug Info

Related News